Skip to main content

Jahanara Miotto to be featured in the Top 50 Fearless Leaders Publication Vol. 2 by IAOTP

New York, NY, United States - 05-23-2022 -

Jahanara Miotto, Founder & President for Metrendalytics LLC, was recently selected to be featured in the 2nd Edition of the Top 50 Fearless Leaders Publication by the International Association of Top Professionals (IAOTP).

While being selected to be published in IAOTP’s Top 50 Fearless Leaders Publication, is an honor, only 50 of the world’s most brilliant, courageous, inspirational professionals are selected for this distinction.

These special honorees are hand selected to share their stories of perseverance, resilience, passion and strength.  Ms. Miotto has made outstanding contributions to society and has made an incredible impact on her industry. A chapter will be dedicated to each honoree and the book is anticipated to be released in the 1st quarter of 2023.

Ms. Miotto will have a dedicated chapter in the 2nd Edition of the Top 50 Fearless Leaders Publication, and she will be honored at IAOTP’s Annual Awards Gala at the Bellagio Hotel, Las Vegas in December for this distinction and as IAOTP’s Top Executive of the Decade in Research & Development of Pharmaceuticals.

As the Founder and President of Metrendalytics LLC since 2014, Ms. Miotto has certainly proven herself as accomplished and she is an expert Executive in Research & Development of Pharmaceuticals. She has more than 3 decades of professional experience in her field. Her impressive repertoire of past roles includes working for Eisai Medical Research, Nexgenix Pharmaceutical, Par Pharmaceutical, Purdue Pharma and Novartis.

Metrendalytics LLC., provides highly customized and flexible solutions, enabling real time data access and advanced business analytics. Helping companies more actively manage operational performance, mitigate risk and shape smarter business decisions. An award-winning platform developed by Scientists, for Scientists.

Ms. Miotto’s areas of expertise encompass a wide range of skills involving Business Management, Operations & Project Management, Clinical Development, Business Analytics, Planning & Finance, Biotechnology, Clinical Trials, Biopharmaceuticals, CRO & CRO Management, Bioanalysis, Clinical Operations, Drug Development and Pharmaceutical Research and Development.

Before embarking on her professional career path, Ms. Miotto attended Queens College where she earned her BA in Chemistry and Mathematics. Furthermore, she graduated with a master’s degree in Analytical Chemistry from CUNY City College.

Aside from her successful career, Ms. Miotto has authored and contributed to over 30 different publications. She holds 2 US Patents and is a sought-after speaker who presents at conferences both nationally and internationally. Ms. Miotto is also heavily involved in a multitude of on-going projects.

Throughout her illustrious career, Ms. Miotto has accepted many awards, accolades and has been recognized worldwide for innovative leadership and commitment to the industry. This year she will be considered for an exclusive interview on T.I.P. Radio, and she was recently broadcasted on the famous Reuters Building in Times Square, New York City.  She will also be considered for the Business Innovator Award and the Lifetime Achievement Award given by the International Association of Top Professionals (IAOTP).

In past years, Ms. Miotto was featured in numerous editions of Marquis Who’s Who and was also honored as a Lifetime Achievement recipient from Worldwide Who’s Who. She was named as one of the 10 Most Influential Women Making a Difference in Healthcare for 2021 and was nominated as the Most Influential Woman in Pharmaceutical Research and Development for 2019.

In addition to these merits, Metrendalytics, Ms. Miotto’s company has been awarded many times for its innovations and reputable services they provide. Some of the titles Metrendalytics recently received was its nomination as one of the 10 Most Innovative Pharma and Biotech Solution Providers as well as becoming shortlisted as one of the Top 30 Innovative Companies to watch.

Looking back, Ms. Miotto attributes her success to her perseverance, her unique hands-on experiences, her education and remaining passionate in all of her business endeavors. In her spare time, she enjoys spending time with her family and traveling. For the future, Ms. Miotto will continue providing her knowledge and enhancing the pharmaceutical industry while helping companies use more modern and innovative methods to achieve their goals.

For more information on Jahanara Miotto please visit: www.metrendalytics.com

About IAOTP

The International Association of Top Professionals (IAOTP) is an international boutique networking organization that handpicks the world’s finest, most prestigious top professionals from different industries.  These top professionals are given an opportunity to collaborate, share their ideas, be keynote speakers, and to help influence others in their fields. This organization is not a membership that anyone can join.  You must be asked by the President or be nominated by a distinguished honorary member after a brief interview.

IAOTP’s experts have given thousands of top prestigious professionals around the world, the recognition and credibility that they deserve and have helped in building their branding empires.  IAOTP prides itself to be a one-of-a-kind boutique networking organization that hand picks only the best of the best and creates a networking platform that connects and brings these top professionals to one place.

For More information on IAOTP please visit:   www.iaotp.com

Media Contacts:

Company Name: IAOTP
Full Name: Stephanie Cirami
Phone: 212 634 4427
Email Address: Send Email
Website: http://www.iaotp.com

For the original news story, please visit https://www.publishedpr.com/news/jahanara-miotto-to-be-featured-in-the-top-50-fearless-leaders-publication-vol-2-by-iaotp/9162541.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.